Cargando…
Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy
Background: In heart transplant recipients, donor-derived cell-free DNA (ddcfDNA) is a potential biomarker for acute rejection (AR), in that increased values may indicate rejection. For the assessment of ddcfDNA as new biomarker for rejection, blood plasma sampling around the endomyocardial biopsy (...
Autores principales: | Verhoeven, Jeroen G. H. P., Hesselink, Dennis A., Peeters, Annemiek M. A., de Jonge, Evert, von der Thüsen, Jan H., van Schaik, Ron H. N., Matic, Maja, Baan, Carla C., Manintveld, O. C., Boer, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977404/ https://www.ncbi.nlm.nih.gov/pubmed/35387397 http://dx.doi.org/10.3389/ti.2022.10122 |
Ejemplares similares
-
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
por: Hurkmans, Daan P., et al.
Publicado: (2019) -
Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
por: El-Rifai, Rasha, et al.
Publicado: (2023) -
Evaluation of Expanded Criteria Donors Using the Kidney Donor Profile Index and the Preimplantation Renal Biopsy
por: Villanego, F., et al.
Publicado: (2022) -
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022) -
Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)